The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.

by Laure-Anne Van Bellinghen, Genevieve Meier, Ilse Van Vlaenderen
Published 2014-01-01

Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to Ghana

by Christophe Sauboin, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, Baudouin Standaert
Published 2019-07-01

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries

by Christophe Sauboin, Laure-Anne Van Bellinghen, Nicolas Van De Velde, Ilse Van Vlaenderen
Published 2019-12-01

Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types

by Laure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, Jorge Gomez, Ilse Van Vlaenderen
Published 2018-01-01